| Brian F. Sullivan |
Brian F. Sullivan was the founder of Recovery Engineering, Inc. (1986) and Celcuity, Inc. (2012), where he held the titles of Chairman & Chief Executive Officer. He is currently the Chairman & Chief Executive Officer at PUR Water Purification Products, Inc. Mr. Sullivan's former positions include Chairman & Chief Executive Officer at SterilMed, Inc. (2002-2011), Co-Chairman at CobornsDelivers LLC (1999-2002), and Director at Sontra Medical Corp. (2004-2007), Virtual Radiologic Corp. (2008-2010), Children's Health Care, Minnesota Orchestral Association, Entegris, Inc. (2003-2021), The R.L. Winston Rod Co., Inc., and North Central Life Insurance Co. Mr. Sullivan received his undergraduate degree from Harvard College. |
| John R. MacDonald |
John R. MacDonald is the founder of Ridge Road Consulting, LLC. He is currently working as the Senior Vice President-R&D at Celcuity, Inc. |
| Nadene Zack |
Nadene Zack is currently working as VP-Clinical Operations at Celcuity, Inc. Prior to this, he worked as Senior Director-Clinical Operations at Daré Bioscience, Inc. He holds a graduate degree from George Washington University and an undergraduate degree from San Diego State University. |
| Igor Gorbatchevsky |
Igor Gorbatchevsky is currently the Chief Medical Officer at Celcuity, Inc. He previously held positions as the Senior Medical Director at Daiichi Sankyo Co., Ltd. from 2009 to 2014, the Vice President-Clinical Development at MEI Pharma, Inc. from 2019 to 2021, and the Vice President-Clinical Science at Iovance Biotherapeutics, Inc. from 2017 to 2018. |
| Lance G. Laing |
Lance G. Laing is the founder of Celcuity, Inc. which was founded in 2012. He held the titles of Secretary, Director & Chief Science Officer. Dr. Laing's former job was as President of Merck Research Laboratories Massachusetts LLC. Dr. Laing received a doctorate degree from The Johns Hopkins University. |
| Pratima Nayak |
Pratima Nayak is currently working as the Vice President-Medical Affairs at Celcuity, Inc. Previously, she worked as the Senior Medical Director at Atara Biotherapeutics, Inc. |
| Eldon C. Mayer |
Eldon C. Mayer is currently the Chief Commercial Officer at Celcuity, Inc. He previously worked as a Marketing Director at ALZA Corp., Associate Director-New Product Planning at Chiron Corp., Marketing Director at Genentech, Inc., Senior Director-Marketing at Connetics Corp., Director at Promet Therapeutics LLC, Director at National Community Oncology Dispensing Association, and Manager-Market Research at Schering-Plough Corp. He also served as Vice President-Commercial Operations at Questcor Pharmaceuticals, Inc. from 2008 to 2012. Additionally, he was the Chief Commercial Officer & Executive VP at Rigel Pharmaceuticals, Inc. from 2016 to 2019 and is currently the Chief Commercial Officer & Executive VP at Eiger BioPharmaceuticals, Inc. from 2018 to 2024. Mr. Mayer received his undergraduate degree from Fairleigh Dickinson University and his MBA from Syracuse University. |
| Vicky Hahne |
Vicky Hahne is currently the Chief Financial Officer at Celcuity, Inc. She previously worked as the Chief Financial Officer at SimonDelivers.com, Inc. from 2000 to 2007. She also held positions as Controller at ABILITY Network, Inc. and SterilMed, Inc. and as Vice President-Finance & Head-Financial Affairs at CobornsDelivers LLC. Additionally, she worked as a Controller at Respiratory Technologies, Inc. from 2015 to 2017. Ms. Hahne received an undergraduate degree from Northern State University. |
| Richard J. Nigon |
Richard J. Nigon is the founder of Cedar Point Capital LLC, which was founded in 2007. He holds the title of Senior Vice President at Cedar Point Capital LLC starting in 2012. Mr. Nigon's current jobs include being the Non-Executive Chairman at Northern Technologies International Corp. since 2010, Director at Spineology, Inc. since 2017, Director at Incisive Surgical, Inc. since 2000, Independent Director at Celcuity, Inc. since 2017, and Director at RxFunction, Inc.Mr. Nigon's former jobs include being a Director at Compex Technologies, Inc. from 2005 to 2006, Director at Endocardial Solutions, Inc., Independent Director at Vascular Solutions LLC from 2000 to 2017, Independent Director at Tactile Systems Technology, Inc. from 2012 to 2022, Director at Virtual Radiologic Corp. from 2007 to 2010, Director at Cymbet Corp., Managing Director-Private Placements at Stifel, Nicolaus & Co., Inc. from 2006 to 2007, Director-Equity Corporate Finance at Miller, Johnson, Steichen, Kinnard, Inc. from 2001 to 2007, Director at Transoma Medical, Inc. from 2006 to 2010, Director at Restore Medical, Inc. from 2006 to 2008, Partner at Ernst & Young LLP from 1981 to 2000, President at NorthStar Education Finance, Inc., and Chief Financial Officer at Dantis, Inc. from 2000 to 2001. Mr. Nigon's education history includes an undergraduate degree from St. John's University. |
| Polly A. Murphy |
Polly A. Murphy is an Independent Director at Atea Pharmaceuticals, Inc., Celcuity, Inc., and Chief Business Officer at UroGen Pharma Ltd. She previously worked as Vice President-Commercial Development at Pfizer Inc. from 2019 to 2020 and as Senior VP-Business & Scientific Services at The Scripps Research Institute from 2005 to 2008. Murphy holds a doctorate from Iowa State University and an MBA from Nova Southeastern University, Inc. |
| David F. Dalvey |
David F. Dalvey is an Independent Director at Celcuity, Inc. and Managing General Partner at Brightstone Capital LLC. He previously served as an Independent Director at Speed Commerce, Inc., Director at CHF Solutions, Inc., AppTec Laboratory Services, Inc., Agiliti, Inc., Definity Health Corp., and Nature Vision, Inc. He was also a Director at Digitiliti, Inc., Navarre Minerals Ltd., and BiteSquad.com LLC. Additionally, he was a Member-Managers Board at Blue Rock Market Neutral Fund LLC. He worked as an Investment Banker at Wessels, Arnold & Henderson LLP and was a Principal at R.J. Steichen & Co. He was also a Managing Partner at Mount Yale Capital Group LLC. Mr. Dalvey received his undergraduate degree from the University of Minnesota and his MBA from The Curtis L. Carlson School of Management. |
| Leo T. Furcht |
Leo T. Furcht is the founder of South Bay Medical. He is currently an Independent Director at Celcuity, Inc. since 2019 and a Professor-Cancer Biology at the University of Minnesota. Previously, he served as the Chairman at University of Minnesota Physicians from 2004 to 2014 and as a Director at GelStat Corp. from 2004 to 2005. |
| Richard E. Buller |
Richard E. Buller is an Independent Director at Celcuity, Inc. He was previously an Independent Director at Rebus Holdings, Inc. and a Director-Oncology Medicine Development Center at GSK Plc. Prior to that, he was the VP & Head-Clinical Development Oncology at Pfizer Inc. and Vice President-Translational Medicine at Exelixis, Inc. He also worked as a Professor-Gynecologic Oncology at the University of Iowa. Buller received his undergraduate degree from the University of California, Los Angeles and his doctorate from Baylor College of Medicine. |
